MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehag254

Медицинская библиотека · European heart journal · 2026

Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact.

Nicolas Johny, Oliva Angelo, Cohen Rebecca, Sartori Samantha, Smith Kenneth F, Di Muro Francesca Maria, Vogel Birgit, Hooda Amit, Sharma Raman, Sweeny Joseph, Stefanini Giulio, Bhatt Deepak L, Kini Annapoorna, Dangas George, Sharma Samin K, Mehran Roxana

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Standard modifiable risk factors (SMuRFs), including hypertension, diabetes, hyperlipidaemia, and smoking, are prevalent among patients undergoing percutaneous coronary intervention (PCI). This study aimed to assess the prevalence and impact of controlled SMuRFs in patients undergoing PCI.

METHODS

Data of patients who underwent PCI at a single tertiary-care centre between 2012 and 2023 were analysed. SMuRF control was assessed using pre-procedural measurements: systolic blood pressure <140 mmHg, fasting glucose <126 mg/dL or a haemoglobin A1c < 7%, low-density lipoprotein <100 mg/dL, and smoking status (non-smoker). Patients were stratified by the number of controlled risk factors (CRF): 4, 3, 2, and ≤1. The primary outcome was major adverse cardiovascular events (MACE), a composite of all-cause mortality, myocardial infarction, and stroke, at one-year post-PCI.

RESULTS

Among 19 651 patients, 5876 (29.9%) had 4-CRF, 8199 (41.7%) had 3-CRF, 4415 (22.5%) had 2-CRF, and 1161 (5.9%) had ≤1-CRF. Compared with 4-CRF, the risk for MACE increased progressively with fewer controlled risk factors (3-CRF: adjHR 1.17, 95% CI 0.98-1.40; 2-CRF: adjHR 1.39, 95% CI 1.14-1.69; ≤1-CRF: adjHR 1.48, 95% CI 1.10-2.00). Glycaemic control had the most significant association with lower MACE (adjHR 0.56, 95% CI 0.49-0.65).

CONCLUSIONS

Comprehensive SMuRF control before PCI remains infrequent, though it is associated with lower MACE rates. Prioritizing glycaemic control may yield the greatest benefit in improving post-PCI prognosis.

Для цитирования: Nicolas Johny, Oliva Angelo, Cohen Rebecca, Sartori Samantha, Smith Kenneth F, Di Muro Francesca Maria, Vogel Birgit, Hooda Amit, Sharma Raman, Sweeny Joseph, Stefanini Giulio, Bhatt Deepak L, Kini Annapoorna, Dangas George, Sharma Samin K, Mehran Roxana. Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact.. European heart journal. 2026. DOI: 10.1093/eurheartj/ehag254.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.